Funded Research
Grant (Rs. In Lakhs)
Ayurveda Grant-in-aid to set up Speciality Clinic of Ayurveda 2.30
Rameshbabu D
Funded by Dept of Indian Systems of Medicine & Homeopathy (Department of AYUSH), Ministry of Health & Family Welfare, Govt. of India, New Delhi, 2007-09
Anatomy Genetic study in human male infertility related to microdeletions 25.00
Of Y chromosome in Idiopathic cases of azoospermia and oligospermia.
Pal AK
Funded by ICMR, 2010
Biochemistry Repository for filarial parasites and reagents 7.00
Reddy MVR, Goswami K
Funded by DBT, 2010-11
Community Effect of Probiotics VSL#3 on Prevention of Sepsis in the 0-2 7.7
Medicine months period: A double blind randomized Controlled Trial
Garg BS, Gupta SS, Maliye CH, Bahulekar PV
Funded by ICMR, 2008 onwards
Dr Sushila Establishment of national quality assurance cell for Emergency 7.7
Nayar School Obstetric Training
of Public Health Garg BS, Maliye C
WHO India Country Office, 2010 onwards
Establishment of state quality assurance cell for Emergency 8.37
Obstetric Training for NIPI States UP, Rajasthan, Bihar, MP and Orissa
Garg BS, Maliye C
WHO India Country Office, 2010 onwards
Establishment of State Quality assurance Cell for Emergency 6.33
Obstetric Training for Non NIPI States Assam, Jharkhand, Maharashtra and Chattisgarh
Garg BS, Maliye C
WHO India Country Office, 2010 onwards
A study of perinatal mortality in Wardha, Maharashtra, India. 1.5
Garg BS, Deshmukh PR, Bharambe MS
WHO SEARO, 2010-11
Dermatology Sexually Transmitted Infections Clinic 1.2
Kar S, MSACS, NACO
JBTDRC, Tropical Disease Research Programme for TB diagnostics 3.00
Bioinformatics Harinath BC
Centre, Funded by KHS, 2009-10
Arogyadham
Assay for circulating Tubercular Antigen level by Sandwich 5.88
ELISA using cocktail of Affinity Purified Antibodies to ES-31, ES-43,
EST-6 Antigens of Diagnostic Interest, in Pulmonary and Lymphnode
tuberculosis and HIV-TB Coinfection
Harinath BC (Fellowship project)
Funded by Tuberculosis Association of India, 2010-11
Sub-Distributed Information Centre under BTISnet Programme 6.81
including grant for 2 Mbps Leased line and additional grant for
SEVAMED.
Harinath BC
Funded by DBT 2010-11
Naturopathy / Yoga Treatment –cum- Propagation Centre 6.00
Harinath BC
Funded by CCRYN, Dept of Ayush, 2010-11
Arogyadham and Herbal Garden 7.54
Harinath BC
Funded by KHS,2010-11
Medicine HOPE 3 : Heart Outcomes Prevention Evaluation 16.0
SP Kalantri, Taksande B
Funded by Population Health Research Institute, Mc Master Uni
Canada, 2009 onwards
INSPIRE : INdian Stroke Prospective REgistry 0.20
SP Kalantri, Jain V
Funded by Population Health Research Institute,
St. John’s Medical College Bangaluru, 2008 onwards
INTERSTROKE: An Indian Pilot case-control study to determine 2.00
the importance of conventional and emerging risk factors for stroke.
Jain VV, Kalantri SP
Funded by Population Health Research Institute,
St. John’s Medical College Bangaluru, 2008 on wards
SPREAD study: A randomized controlled trial in secondary *
prevention of acute coronary syndrome
SP Kalantri, Taksande B, Jain V
Funded by Population Health Research Institute,
St. John’s Medical College Bangaluru, 2011
Insurance Audit 10.51
Jajoo UN, Kalantri SP, Joshi R
Funded by ICMR, New Delhi, 2010 onwards
PREPARE study: A household-level cluster-randomized trial to *
evaluate primary prevention interventions in CVD in three rural communities (population of 15,000)
SP Kalantri, Yelwatkar S
Funded by Population Health Research Institute,
St. John’s Medical College Bangaluru, 2011 onwards
DIABETES HCQS: A double blind randomized controlled trial to 2.56
determine the efficacy of Hydroxychloroquine vs. Pioglitazone on uncontrolled type 2 Diabetes mellitus patients.
Gupta OP, Jain V
Funded by Ipca laboratories, Mumbai, 2010-11
Microbiology Survey on Prevalence of TB in Wardha district 1.17
Narang P, Mendiratta DK, Jajoo UN, Tyagi NK, Narang R, Tayde A
Funded by Central TB Division, New Delhi, 2006 onwards
Repeat zonal level Tuberculin survey for estimating annual risk 65.10
of tuberculosis Infection in different parts of India (RARTI)
Narang P, Mendiratta DK
Funded by Central TB Division, New Delhi since July, 2009
Multi Center study on antimicrobial resistance monitoring of 0.60
Salmonella Typhi and Salmonella Paratyphi – A : An attempt to make national
guidelines to treat Enteric fever
Mendiratta DK, Thamke D
Funded by ICMR - since June 2010
Confirmation of diseases of public health importance under the 3.00
IDSP (Integrated Disease surveillance Project) State surveillance
net work (Referal Lab.)
Mendiratta DK, Deotale V
Funded by Maharashtra State Govt. - 2010 – 2013
Obs/ Gyn and Prevention of parent to child transmission of HIV / AIDS *
Microbiology Chhabra S, Mendiratta DK
Funded by Govt of Maharashtra, since 17 Sep, 2002 onwards
Obstetrics and Emergency Obstetric Care 13.87
Gynecology Chhabra S, Shivkumar PV
Funded by Govt of Maharashtra, Govt of India, FOGSI,
AVNI Foundation, 2008 onwards
Amnisure Project 9.34
Chhabra S
Funded by Amnisure Company, 2009 onwards
Thiamine Project 13.87
Chhabra S
Funded by Foundation of Collaboration Medicine and Research,
USA, 2010 onwards In Collaboration with Pharmacology
Maternal death audit 1.12
Shivkumar PV, Tayade S
Funded by GOI, FIGO, AVNI, 2010 onwards
Anaemia Project 37.63
Chhabra S
Funded by CCRS (Ayush) GOI, 2011 onwards
Ophthalmology Sentinel Surveillance Unit (Under National Programme for Control of 2.00
Blindness) Shukla AK , Garg BS, Singh S, Mehendale AM
Funded by Ministry of Health and Family Welfare Govt. of India, 2010 -11
Pathology Rural Population Based Cancer Registry of Wardha District 12.50
Gangane N
ICMR , 2010 onwards
Expression of vascular endothelial growth factor (VEGF) protein 3.70
In endometrium of women with menorrhagia and its correlation with endothelial cell proliferation
Gangane N, Chhabra S, Joshi D
ICMR, 2010 onwards
p53 and ras mutations in oral cancer in Central India 4.50
Gangane N
UICC and NIH, 2010 onwards
Pediatrics Low birth weight neonates and maternal chronic diseases risk 4.69
factors in a rural population.
Bang A, Joshi R, Vilhekar KY
Funded by St Johns’ Research Institute,
Bangalore as NIH-NHLBI Center of Excellence, 2009-2011
India CLEN Multicentre Trial of Home versus Hospital Oral 5.41
Amoxicillin for Management of Severe Pneumonia in Children”
(ISPOT STUDY)
Bang A, Jain M, Vilhekar KY, Mendiratta DK
Funded by USAID and MCH-STAR through IndiaCLEN, 2009-2011
A phase III multicentric randomized single blind trial to compare 0.80
the immunogenicity and safety of TETRABHAY DTwP-H combination vaccine with SHANTETRAtm in healthy infants.
Jain M, Bang A
Funded by SRISTEK, Hyderabad, 2009-2010
Japanese Encephalitis Vaccine phase II / III clinical study: A 5.00
multicentric open label randomized controlled phase II / III study to evaluate the safety and immunogenicity of Biological E Ltd
inactivated JE vaccine in healthy 1-3 years old Indian children.
Jain M, Bang A
Funded by SRISTEK, Hyderabad, 2010-2011
ASIP study- Hospital based surveillance of invasive 5.00
pneumococcal disease
Mendiratta DK, Bang A
Funded by CMC,Vellore, 2010-2013
A randomized multicenter open label comparative study to 7.50
evaluate the immunogenicity and reactogenicity of a new fully
liquid pentavalent DTwP-HIB-IPV vaccine with tetravalent DTwP/HIB vaccine coadministered with Salk Based IPV in healthy infants.
Jain M, Bang A
Funded by SRISTEK, Hyderabad, 2010-2011
A multicentric, single blind, parallel, randomized, phase-IV non- 3.50
inferiority study for immunogenicity and safety of BE’s combined
liquid pentavalent DTwP-rHepB-HIB vaccine in comparison with
SIIL’s Pentavac SD™ vaccine
Jain M, Bang A
Funded by SRISTEK, Hyderabad, 2010-2011
A multicentric double blind single arm randomised phase-IV 3.50
study to evaluate the safety, reactogenicity and lot consistency of 3 production lots of BE’s combined liquid pentavalent DTwP-rHepB-HIB
vaccine
Jain M, Bang A
Funded by SRISTEK, Hyderabad, 2010-2011
Psychiatry Effect of Ayurvedic coded drug (Ayush Manas) in the 37.79
management of Manasa Mandata (MR)
Behere PB
Funded by Central Council for Research in Ayurveda & Siddha, AYUSH, Government of India.
A Phase 3 randomized, double-blind, active comparator- 28.11
controlled clinical trial to study the safety and efficacy of
Lurasidone in subjects with schizophrenia (Pearl 3 Extension
Study)
Behere PB
Funded by Sunovion, 2010
Randomized, 6-week, double-blind, placebo-controlled, flexible- 20.17
dose, parallel-group study of Lurasidone adjunctive to lithium or
valproate for the treatment of bipolar I depression in subjects
demonstrating non-response to treatment with lithium or valproate Alone
Behere PB
Funded by Sunovion, 2010